Search research articles
Contact Us
Filters
Showing results (41-50 of 442) with videos related to
Page
of 45
Sort By:
American Journal of Clinical Dermatology
|
June 9, 2022
JAK in the [Black] Box: A Dermatology Perspective on Systemic JAK Inhibitor Safety
Sarina B Elmariah, Jeffrey S Smith, Joseph F Merola
Dermatology Online Journal
|
July 17, 2008
Cutaneous Rosai-Dorfman disease
Joseph F Merola, Melissa Pulitzer, Karla Rosenman, et al.
International Journal of Women'S Dermatology
|
May 12, 2017
Classifying discoid lupus erythematosus: background, gaps, and difficulties
Jessica S Haber, Joseph F Merola, Victoria P Werth
International Journal of Dermatology
|
June 2, 2021
Tofacitinib for refractory chilblain lupus erythematosus
Scott A Elman, Daniel R Mazori, Joseph F Merola
Current Opinion in Pharmacology
|
October 13, 2022
Current and emerging biologic and small molecule systemic treatment options for psoriasis and psoriatic arthritis
Christine P Lin, Joseph F Merola, Elizabeth B Wallace
JAAD Case Reports
|
September 13, 2023
A case of paradoxical eosinophilic fasciitis in a patient on benralizumab
Michael J Woodbury, Rebecca G Gaffney, Joseph F Merola
Annals of Translational Medicine
|
April 12, 2021
Evaluating safety and compatibility of anti-tumor necrosis factor therapy in patients with connective tissue disorders
Jordan T Said, Scott A Elman, Joseph F Merola
Clinical Rheumatology
|
January 16, 2021
Pseudovasculitis: an etiology not to miss
Scott A Elman, Daniel R Mazori, Joseph F Merola
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1992
Thyroid uptake neck phantoms are not created equal
G A Vahjen, R C Lange, T F Merola
The Journal of Rheumatology
|
September 3, 2013
Screening instruments for psoriatic arthritis
Joseph F Merola, M Elaine Husni, Abrar A Qureshi
Page
of 45
Search research articles
Search
Showing results (41-50 of 442) with videos related to
Sort By:
Page
of 45
American Journal of Clinical Dermatology
|
June 9, 2022
JAK in the [Black] Box: A Dermatology Perspective on Systemic JAK Inhibitor Safety
Sarina B Elmariah, Jeffrey S Smith, Joseph F Merola
Dermatology Online Journal
|
July 17, 2008
Cutaneous Rosai-Dorfman disease
Joseph F Merola, Melissa Pulitzer, Karla Rosenman, et al.
International Journal of Women'S Dermatology
|
May 12, 2017
Classifying discoid lupus erythematosus: background, gaps, and difficulties
Jessica S Haber, Joseph F Merola, Victoria P Werth
International Journal of Dermatology
|
June 2, 2021
Tofacitinib for refractory chilblain lupus erythematosus
Scott A Elman, Daniel R Mazori, Joseph F Merola
Current Opinion in Pharmacology
|
October 13, 2022
Current and emerging biologic and small molecule systemic treatment options for psoriasis and psoriatic arthritis
Christine P Lin, Joseph F Merola, Elizabeth B Wallace
JAAD Case Reports
|
September 13, 2023
A case of paradoxical eosinophilic fasciitis in a patient on benralizumab
Michael J Woodbury, Rebecca G Gaffney, Joseph F Merola
Annals of Translational Medicine
|
April 12, 2021
Evaluating safety and compatibility of anti-tumor necrosis factor therapy in patients with connective tissue disorders
Jordan T Said, Scott A Elman, Joseph F Merola
Clinical Rheumatology
|
January 16, 2021
Pseudovasculitis: an etiology not to miss
Scott A Elman, Daniel R Mazori, Joseph F Merola
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
February 1, 1992
Thyroid uptake neck phantoms are not created equal
G A Vahjen, R C Lange, T F Merola
The Journal of Rheumatology
|
September 3, 2013
Screening instruments for psoriatic arthritis
Joseph F Merola, M Elaine Husni, Abrar A Qureshi
Page
of 45